Hopkins Robert O 4
4 · Adamis Pharmaceuticals Corp · Filed Nov 24, 2020
Insider Transaction Report
Form 4
Hopkins Robert O
Chief Financial Officer
Transactions
- Sale
Common Stock
2020-11-20$0.41/sh−35,000$14,182→ 254,810 total
Footnotes (2)
- [F1]The sales reported in this Form 4 were for the sole purpose of satisfying or paying income or withholding tax obligations of the undersigned.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.4028 to $0.4076, inclusive. The reporting person undertakes to provide Adamis Pharmaceuticals Corporation, any security holder of Adamis Pharmaceuticals Corporation, or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.